Related Experiment Video
Updated: Sep 9, 2025
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Local excision versus total mesorectal excision following neoadjuvant chemoradiotherapy for rectal cancer: A
McLoughlin Morgan1, Creavin Ben1, McCullough Peter1
1Colorectal Surgery Department, University Hospital Waterford, Ireland.
Background:
Total mesorectal excision (TME) with or without neoadjuvant chemoradiotherapy remains the gold standard treatment for rectal cancer. However, newer organ sparing methods, including Local Excision (LE) have been introduced in conjunction with neoadjuvant therapy to improve morbidity and functional outcomes while not impacting on oncological outcomes.
Methods:
A systematic review and meta-analysis was performed using the PRISMA guidelines. All studies comparing neoadjuvant chemoradiotherapy and local excision versus TME were included from 2000 to 2024. Primary endpoint included local recurrence rates. Secondary outcomes included distant recurrence, disease free survival (DFS), overall survival (OS), and morbidity. Subgroup analysis was performed on randomised control trials (RCT).
Results:
Sixteen studies (n = 2121; LE = 616, TME = 1505) were included. LE was associated with higher local recurrence (8.3 % vs 5.5 %; OR 1.82, 95 % CI 1.19-2.77, p = 0.006). However, in RCTs (n = 245), this difference was not significant (7.3 % vs 6.6 %; OR 1.10, 95 % CI 0.41-2.97, p = 0.84). No significant differences were observed in distant recurrence, DFS, or OS. LE was associated with significantly reduced morbidity (OR 0.30, 95 % CI 0.18-0.50, p < 0.0001).
Conclusion:
Local recurrence was not statistically significant in the RCT subgroup analysis. Despite, higher local recurrence rates in the overall pooled analysis, no significant differences were observed for secondary outcomes. Neoadjuvant chemoradiotherapy and local excision appears oncologically safe, defined by DFS and OS, in select patient cohorts with a clinical complete or near-complete response to neoadjuvant therapy.
More Related Videos
08:26Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
05:43The Role of Anatomical Dissection in Defining Colic and Small Bowel Artery Lymphovascular Bundles in the D3 Volume of Small and Large Bowel Mesentery
Published on: August 1, 2025